TGFA and pulmonary fibrosis: Inhibition of mTORC1 with rapamycin has been used as an effective treatment for TGF‐α‐induced pulmonary fibrosis caused by chronic inflammation (Korfhagen et al., 2009), but is ineffective at treating TGFβ1‐induced pulmonary fibrosis.